Suppr超能文献

慢性胰腺炎患者通过包括抗氧化剂在内的优化药物治疗和逐步强化介入治疗实现长期疼痛缓解。

Long-term pain relief with optimized medical treatment including antioxidants and step-up interventional therapy in patients with chronic pancreatitis.

作者信息

Midha Shallu, Hasan Ajmal, Dhingra Rajan, Garg Pramod Kumar

机构信息

Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

J Gastroenterol Hepatol. 2017 Jan;32(1):270-277. doi: 10.1111/jgh.13410.

Abstract

BACKGROUND AND AIM

Abdominal pain is difficult to treat in patients with chronic pancreatitis (CP). Medical therapy including antioxidants has been shown to relieve pain of CP in the short-term. Our aim was to study the long-term results of optimized medical and interventional therapy for pain relief in patients with CP with a step-up approach.

METHODS

All consecutive patients with CP were included prospectively in the study. They were treated medically with a well-balanced diet, pancreatic enzymes, and antioxidants (9000 IU beta-carotene, 0.54 g vitamin C, 270 IU vitamin E, 600 µg organic selenium, and 2 g methionine). Endoscopic therapy and/or surgery were offered if medical therapy failed. Pain relief was the primary outcome measure.

RESULTS

A total of 313 patients (mean age 26.16 ± 12.17; 244 males) with CP were included; 288 (92%) patients had abdominal pain. The etiology of CP was idiopathic in 224 (71.6%) and alcohol in 82 (26.2%). At 1-year follow-up, significant pain relief was achieved in 84.7% of patients: 52.1% with medical therapy, 16.7% with endoscopic therapy, 7.6% with surgery, and 8.3% spontaneously. The mean pain score decreased from 6.36 ± 1.92 to 1.62 ± 2.10 (P < 0.001). Of the 288 patients, 261, 218, 112, and 51 patients were followed up for 3, 5, 10, and 15 years, respectively; 54.0%, 57.3%, 60.7%, and 68.8% of them became pain free at those follow-up periods.

CONCLUSION

Significant pain relief is achieved in the majority of patients with optimized medical and interventional treatment.

摘要

背景与目的

慢性胰腺炎(CP)患者的腹痛难以治疗。包括抗氧化剂在内的药物治疗已被证明可在短期内缓解CP患者的疼痛。我们的目的是采用逐步递进的方法研究优化药物和介入治疗缓解CP患者疼痛的长期效果。

方法

所有连续性CP患者均前瞻性纳入本研究。他们接受了均衡饮食、胰酶和抗氧化剂(9000国际单位β-胡萝卜素、0.54克维生素C、270国际单位维生素E、600微克有机硒和2克蛋氨酸)的药物治疗。如果药物治疗失败,则提供内镜治疗和/或手术治疗。疼痛缓解是主要结局指标。

结果

共纳入313例CP患者(平均年龄26.16±12.17岁;男性244例);288例(92%)患者有腹痛。CP的病因在224例(71.6%)中为特发性,82例(26.2%)为酒精性。在1年随访时,84.7%的患者疼痛得到显著缓解:药物治疗缓解的占52.1%,内镜治疗缓解的占16.7%,手术治疗缓解的占7.6%,自发缓解的占8.3%。平均疼痛评分从6.36±1.92降至1.62±2.10(P<0.001)。288例患者中,分别有261例、218例、112例和51例患者接受了3年、5年、10年和15年的随访;在这些随访期内,他们中分别有54.0%、57.3%、60.7%和68.8%的患者疼痛消失。

结论

大多数CP患者通过优化的药物和介入治疗可实现显著的疼痛缓解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验